Medicinal Chemistry and Drug Discovery: A Review of Recent Advances and Multidisciplinary Approaches
Keywords:
Drug Discovery, Medicinal Chemistry, Multidisciplinary Approaches, Artificial Intelligence, Machine Learning, Drug Delivery, Targeted Therapies, Gene-Based TreatmentsAbstract
The goal of the dynamic area of drug development is to find new therapeutic molecules to treat a variety of illnesses. In order to provide patient-centered care, healthcare experts from several disciplines collaborate via the multidisciplinary approach. This article reviews the many studies on the latest developments and interdisciplinary methods in drug discovery and medicinal chemistry. This review highlight that the medicinal chemistry and drug discovery have undergone transformative advancements through multidisciplinary collaborations and technological innovations. BTA-based compounds have shown broad therapeutic potential, including anticancer, antibacterial, and anti-inflammatory properties. The integration of artificial intelligence, machine learning, high-throughput screening, and rational drug design has accelerated drug development. Targeted therapies, gene-based treatments, and nanotechnology-driven drug delivery systems have improved efficacy and patient compliance. Collaborative efforts among chemists, pharmacologists, and clinicians enhance treatment outcomes, minimize toxicity, and address unmet medical needs. This multidisciplinary approach fosters innovation, clinical standardization, and improved healthcare delivery, ultimately leading to more effective, personalized, and patient-centered therapies.
References
[1] D. Castagnolo, P. Sarkar, and D. Schulz, "Looking back and moving forward in medicinal chemistry," Nat. Commun., vol. 14, 2023,https://doi.org/10.1038/s41467-023-39949-6
[2] J. J. Vanden Eynde et al., "Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes-6," Molecules, vol. 25, 2020.
[3] C. A. Dodson, S. E. Flower, and M. Thomas, "A Multidisciplinary Team-Based Classroom Exercise for Small Molecule Drug Discovery," J. Chem. Educ., vol. 100, 2023,https://doi.org/10.1021/acs.jchemed.3c00066
[4] W. Cui, A. Aouidate, S. Wang, Q. Yu, Y. Li, and S. Yuan, "Discovering Anti-Cancer Drugs via Computational Methods," Front. Pharmacol., vol. 11, no. May, pp. 1-14, 2020,https://doi.org/10.3389/fphar.2020.00733
[5] B. Yu, X. Lu, and J. Chang, "Multidisciplinary Training for Fostering Next-Generation Medicinal Chemists," J. Med. Chem., vol. 67, 2024,https://doi.org/10.1021/acs.jmedchem.4c02316
[6] J. Ingham, J.-L. Ruan, and M. A. Coelho, "Breaking barriers: we need a multidisciplinary approach to tackle cancer drug resistance.," BJC reports, vol. 3, no. 1, 2025,https://doi.org/10.1038/s44276-025-00129-2
[7] R. R. Ramsay and G. Di Giovanni, "Editorial: Structure-based drug design for diagnosis and treatment of neurological diseases," Front. Pharmacol., vol. 8, no. JAN, pp. 1-2, 2017,https://doi.org/10.3389/fphar.2017.00013
[8] A. R. Sj and N. P. Shetty, "Advances in designing Next-generation drugs from Natural products," pp. 1-21, 2024.
[9] J. S. Shim and J. O. Liu, "Recent advances in drug repositioning for the discovery of new anticancer drugs," Int. J. Biol. Sci., vol. 10, no. 7, 2014,https://doi.org/10.7150/ijbs.9224
[10] G. Wu et al., Overview of Recent Strategic Advances in Medicinal Chemistry, vol. 62. 2019.https://doi.org/10.1021/acs.jmedchem.9b00359
[11] I. Cacciatore and L. Marinelli, "Microbial Infections and Wound Healing: Medicinal-Chemistry and Technological Based Approaches," Pharmaceutics, vol. 16, 2024,https://doi.org/10.3390/pharmaceutics16020168
[12] V. Gallego, R. Naveiro, C. Roca, D. Ríos Insua, and N. E. Campillo, "AI in drug development: a multidisciplinary perspective," Mol. Divers., vol. 25, 2021,https://doi.org/10.1007/s11030-021-10266-8
[13] J. Jiménez-Luna, F. Grisoni, N. Weskamp, and G. Schneider, "Artificial intelligence in drug discovery: recent advances and future perspectives," Expert Opin. Drug Discov., vol. 16, no. 9, 2021,https://doi.org/10.1080/17460441.2021.1909567
[14] W. Jiang and Z. Zhao, "Trends in research on AI-aided drug discovery from 2009 to 2023: A 15-year bibliometric analysis," Intell. Pharm., vol. 3, no. 1, 2025,https://doi.org/10.1016/j.ipha.2024.09.001
[15] G. M. Amle and R. K. Wanare, "Advances in Medicinal Chemistry : Multidisciplinary Approaches to Drug Design, Synthesis, and Evaluation," Int. J. Sci. Res. Sci. Technol., vol. 12, no. 11, 2025.
[16] N. D. Badgujar et al., "Recent Advances in Medicinal Chemistry with Benzothiazole-Based Compounds: An In-Depth Review," J. Chem. Rev., vol. 6, no. 2, 2024,doi: 10.48309/jcr.2024.436111.1290.
[17] M. K. Khan et al., "The recent advances in the approach of artificial intelligence (AI) towards drug discovery," Front. Chem., vol. 12, 2024,https://doi.org/10.3389/fchem.2024.1408740
[18] N. Korylchuk, V. Pelykh, Y. Nemyrovych, N. Didyk, and S. Martsyniak, "Challenges and Benefits of a Multidisciplinary Approach to Treatment in Clinical Medicine," J. Pioneer. Med. Sci., vol. 13, no. 3, 2024,https://doi.org/10.61091/jpms202413301
[19] R. Patel, N. Kumar Verma, S. Singh, and U. Srivastava, "The Promising Applications of Artificial Intelligence in Drug Development and Discovery," Int. J. Multidiscip. Res. Sci. Eng. Technol., vol. 7, no. 8, 2024,doi: 10.15680/IJMRSET.2024.0708061.
[20] I. Pibiri, "Recent Advances: Heterocycles in Drugs and Drug Discovery," Int. J. Mol. Sci., vol. 25, 2024,https://doi.org/10.3390/ijms25179503
[21] A. Premalatha, M. Atul Bora, D. S. Bhoomandla, and A. Kumari Nakkella, "Recent Advances in Drug Discovery: Innovative Approaches and Targeted Therapeutics," Eur. Chem. Bull., vol. 12, 2023.
[22] S. Lin et al., "Recent Advances of Pyridinone in Medicinal Chemistry," Front. Chem., vol. 10, 2022,https://doi.org/10.3389/fchem.2022.869860
